Asian insurers recoil from structured products

The poor take-up of derivatives-based investments by Asian life companies is blamed on institutional and regulatory barriers

Life insurers in Hong Kong are conservative

Asian insurers are put off investing in structured products by a deep-seated suspicion of the asset class among their boards of directors and by high regulatory capital charges, delegates heard at the Structured Products Asia conference in Hong Kong.

Recommending such investments can even be a career risk for employees, according to one speaker.

Board members still remember the heavy losses some of the region's insurance companies suffered on their portfolios of collateralised debt obligations

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here